Inspire Medical Systems, Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
8
Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
INSP
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $72.25 (+27.4%)
12 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
INSP
PFE
11.6×
Trailing P/E
19.4×
21.9×
Forward P/E
9.4×
15.9%
Profit Margin
12.4%
85.4%
Gross Margin
75.8%
19.8%
ROE
8.9%
12.2%
Revenue Growth
-1.2%
308.4%
Earnings Growth
—
0.86
Beta
0.39
—
Price / Book
—
$1.6B
Market Cap
$149.8B
$48 – $163
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →